Cargando…

Factors associated with early discontinuation of anamorelin in patients with cancer-associated cachexia

PURPOSE: Cancer-associated cachexia, a multifactorial syndrome involving loss of muscle mass and anorexia, is an unremitting problem for cancer patients. Anamorelin has become available for cancer-associated cachexia, but early discontinuation is common in clinical practice. This study aimed to expl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsukiyama, Ikuto, Iwata, Takashi, Takeuchi, Tomoko, Kato, Ryoko Inuzuka, Sakuma, Masaki, Tsukiyama, Sumiyo, Kato, Mana, Ikeda, Yoshiaki, Ohashi, Wataru, Kubo, Akihito, Mori, Naoharu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564655/ https://www.ncbi.nlm.nih.gov/pubmed/37815652 http://dx.doi.org/10.1007/s00520-023-08097-4

Ejemplares similares

Cost‐effectiveness of aprepitant in Japanese patients treated with cisplatin‐containing highly emetogenic chemotherapy
por: Tsukiyama, Ikuto, et al.
Publicado: (2018)

Evidence for partial pharmaceutical reversal of the cancer anorexia–cachexia syndrome: the case of anamorelin
por: Anker, Stefan D, et al.
Publicado: (2015)

Anamorelin hydrochloride in the treatment of cancer anorexia–cachexia syndrome: design, development, and potential place in therapy
por: Graf, Solomon A, et al.
Publicado: (2017)

Combination therapy with anamorelin and a myostatin inhibitor is advantageous for cancer cachexia in a mouse model
por: Hanada, Kako, et al.
Publicado: (2022)

Oncology Update: Anamorelin
por: Prommer, Eric
Publicado: (2017)

Impact of the Extent of Weight Loss before Administration on the Efficacy of Anamorelin in Advanced Pancreatic Cancer Patients with Cachexia
por: Takeda, Tsuyoshi, et al.
Publicado: (2022)

Predictors of efficacy of anamorelin in patients with non‑small cell lung cancer and cachexia: A retrospective study
por: Ishioka, Yoshiko, et al.
Publicado: (2023)

A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in advanced gastrointestinal cancer patients with cancer cachexia
por: Hamauchi, Satoshi, et al.
Publicado: (2019)

Efficacy and safety of anamorelin in patients with cancer cachexia: Post‐hoc subgroup analyses of a placebo‐controlled study
por: Takayama, Koichi, et al.
Publicado: (2022)

The efficacy and safety of anamorelin for patients with cancer-related anorexia/cachexia syndrome: a systematic review and meta-analysis
por: Taniguchi, Jumpei, et al.
Publicado: (2023)

Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile
por: Pietra, Claudio, et al.
Publicado: (2014)

A case of squamous cell lung cancer treated with anamorelin in combination with a multidisciplinary collaborative approach for treating cancer cachexia
por: Oshima, Yuri, et al.
Publicado: (2022)

Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial
por: Takayama, Koichi, et al.
Publicado: (2016)

A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in patients with cancer cachexia and low body mass index
por: Naito, Tateaki, et al.
Publicado: (2022)

Refractory Monomorphic Ventricular Tachycardia Induced by Anamorelin
por: Sakagami, Hiroaki, et al.
Publicado: (2022)

Perspectives of registered dietitians and factors associated with their personal accomplishment in the management of cancer cachexia
por: Koshimoto, Saori, et al.
Publicado: (2023)

ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia
por: Currow, D., et al.
Publicado: (2017)

Efficacy of Anamorelin, a Novel Non-Peptide Ghrelin Analogue, in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Cachexia—Review and Expert Opinion
por: Currow, David C., et al.
Publicado: (2018)

The regulatory approval of anamorelin for treatment of cachexia in patients with non‐small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.
por: Wakabayashi, Hidetaka, et al.
Publicado: (2020)

A retrospective cohort study for the treatment of Asian diabetic ketoacidosis: optimizing initial doses of insulin
por: Hishida, Yoshiaki, et al.
Publicado: (2021)

Effects of the ghrelin receptor agonist anamorelin on lean body mass in cancer patients with cachexia; results from a Phase II randomized, double blind, multicenter study
por: Garcia, Jose M, et al.
Publicado: (2014)

Appetite and food intake results from phase I studies of anamorelin
por: Blum, Robert A., et al.
Publicado: (2019)

A Comprehensive System for Generation and Evaluation of Induced Pluripotent Stem Cells Using piggyBac Transposition
por: Tsukiyama, Tomoyuki, et al.
Publicado: (2014)

Relapse and its modifiers in major depressive disorder after antidepressant discontinuation: meta-analysis and meta-regression
por: Kishi, Taro, et al.
Publicado: (2022)

Perspectives of Health Care Professionals on Multimodal Interventions for Cancer Cachexia
por: Amano, Koji, et al.
Publicado: (2022)

Multiple Systemic Embolization Associated with Chest Compression in a Patient with Cardiac Arrest
por: Miyatani, Kazuki, et al.
Publicado: (2023)

Anamorelin (ONO‐7643) for the treatment of patients with non–small cell lung cancer and cachexia: Results from a randomized, double‐blind, placebo‐controlled, multicenter study of Japanese patients (ONO‐7643‐04)
por: Katakami, Nobuyuki, et al.
Publicado: (2017)

Effects of Elobixibat in Patients with Diabetes and Concomitant Chronic Constipation: an 8-week, Prospective, Single-center, Single-arm Study
por: Hishida, Yoshiaki, et al.
Publicado: (2022)

A Cost-Effectiveness Analysis of Gemcitabine plus Cisplatin Versus Gemcitabine Alone for Treatment of Advanced Biliary Tract Cancer in Japan
por: Tsukiyama, Ikuto, et al.
Publicado: (2016)

Role of Oxidative Stress in Hepatocarcinogenesis Induced by Hepatitis C Virus
por: Tsukiyama-Kohara, Kyoko
Publicado: (2012)

First case report of anamorelin-induced fatal arrhythmia complicated by sinus arrest and refractory ventricular tachycardia
por: Kojima, Keisuke, et al.
Publicado: (2022)

A Modified EpiSC Culture Condition Containing a GSK3 Inhibitor Can Support Germline-Competent Pluripotency in Mice
por: Tsukiyama, Tomoyuki, et al.
Publicado: (2014)

Establishment of Trophoblast Stem Cells under Defined Culture Conditions in Mice
por: Ohinata, Yasuhide, et al.
Publicado: (2014)

Cross-attention PHV: Prediction of human and virus protein-protein interactions using cross-attention–based neural networks
por: Tsukiyama, Sho, et al.
Publicado: (2022)

ICAN: Interpretable cross-attention network for identifying drug and target protein interactions
por: Kurata, Hiroyuki, et al.
Publicado: (2022)

An open-label clinical trial of the effects of age and gender on the pharmacodynamics, pharmacokinetics and safety of the ghrelin receptor agonist anamorelin
por: Leese, Philip T, et al.
Publicado: (2015)

Randomised placebo-controlled cross-over study examining the role of anamorelin in mesothelioma (The ANTHEM study): rationale and protocol
por: Hoon, Siao Nge, et al.
Publicado: (2020)

Pathophysiology of cachexia and characteristics of dysphagia in chronic diseases
por: Matsuo, Haruyo, et al.
Publicado: (2022)

ATP-dependent chromatin remodeling shapes the long noncoding RNA landscape
por: Alcid, Eric A., et al.
Publicado: (2014)

DNA looping-dependent targeting of a chromatin remodeling factor
por: Yadon, Adam N., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_u41oaikov90uh9doqgphj9getu